Cardiac anaphylaxis: pathophysiology and therapeutic perspectives

Area of Science:

• Cardiovascular Physiology
• Immunology
• Pharmacology

Background:

• Cardiac anaphylaxis involves functional and metabolic heart changes.
• Histamine release from mast cells and basophils is central to its pathophysiology.
• Endogenous mechanisms regulate cardiac mast cell activation and histamine release.

Purpose of the Study:

• To review new findings and trends in cardiac anaphylaxis.
• To explore endogenous regulatory mechanisms of cardiac mast cell activation.
• To discuss potential therapeutic targets for novel anti-anaphylactic drugs.

Main Methods:

• Review of experimental animal models of cardiac anaphylaxis.
• Analysis of endogenous mechanisms controlling mast cell activation (adrenergic, H2 receptors, NO, CO).
• Discussion of therapeutic strategies targeting these mechanisms.

Main Results:

• Histamine is a key mediator in cardiac anaphylaxis.
• Adrenergic neural control, H2 receptor feedback, and NO/CO generation modulate mast cell activity.
• Substances targeting these mechanisms show efficacy in preclinical models.

Conclusions:

• Endogenous mechanisms offer promising targets for treating cardiac anaphylaxis.
• Novel anti-anaphylactic drugs can be developed by modulating these pathways.
• Further research into these targets could lead to new therapeutic interventions.